Want to see TSE:ASTI full AI Analyst Report?
Total Valuation
Aquarius Surgical Technologies has a market cap or net worth of C$551.98K. The enterprise value is C$0.84.
Market CapC$551.98K
Enterprise ValueC$0.84
Share Statistics
Aquarius Surgical Technologies has 27,599,173 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,599,173
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aquarius Surgical Technologies’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -49.51%.
Return on Equity (ROE)0.10
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-49.51%
Return on Capital Employed (ROCE)4.71
Revenue Per Employee30.48K
Profits Per Employee-217.24K
Employee Count3
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aquarius Surgical Technologies is ―. Aquarius Surgical Technologies’s PEG ratio is 0.01.
PE Ratio―
PS Ratio4.53
PB Ratio-0.06
Price to Fair Value-0.06
Price to FCF-3.56
Price to Operating Cash Flow-4.74
PEG Ratio0.01
Income Statement
In the last 12 months, Aquarius Surgical Technologies had revenue of 91.44K and earned -651.71K in profits. Earnings per share was -0.02.
Revenue91.44K
Gross Profit33.48K
Operating Income-257.48K
Pretax Income-645.57K
Net Income-651.71K
EBITDA-241.88K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -116.36K and capital expenditures -2.00, giving a free cash flow of -116.36K billion.
Operating Cash Flow-116.36K
Free Cash Flow-116.36K
Free Cash Flow per Share>-0.01
Dividends & Yields
Aquarius Surgical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change33.33%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)97.75
Average Volume (3m)6.90K
Important Dates
Aquarius Surgical Technologies upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateJul 27, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
Aquarius Surgical Technologies as a current ratio of 0.06, with Debt / Equity ratio of -108.09%
Current Ratio0.06
Quick Ratio0.06
Debt to Market Cap16.77
Net Debt to EBITDA-28.53
Interest Coverage Ratio-0.64
Taxes
In the past 12 months, Aquarius Surgical Technologies has paid 6.14K in taxes.
Income Tax6.14K
Effective Tax Rate>-0.01
Enterprise Valuation
Aquarius Surgical Technologies EV to EBITDA ratio is -30.24, with an EV/FCF ratio of -62.86.
EV to Sales79.99
EV to EBITDA-30.24
EV to Free Cash Flow-62.86
EV to Operating Cash Flow-62.86
Balance Sheet
Aquarius Surgical Technologies has C$44.51K in cash and marketable securities with C$6.94M in debt, giving a net cash position of -C$6.90M billion.
Cash & Marketable SecuritiesC$44.51K
Total DebtC$6.94M
Net Cash-C$6.90M
Net Cash Per Share-C$0.25
Tangible Book Value Per Share-C$0.23
Margins
Gross margin is 43.92%, with operating margin of -281.59%, and net profit margin of -712.75%.
Gross Margin43.92%
Operating Margin-281.59%
Pretax Margin-706.03%
Net Profit Margin-712.75%
EBITDA Margin-264.53%
EBIT Margin-281.59%
Analyst Forecast
The average price target for Aquarius Surgical Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast0.26%
EPS Growth Forecast44.21%